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E-mail address: anakao@yamanashi.ac.jp (A. NakaA major house dust mite allergen Der f 1 belongs to the papain-like cysteine protease family. This
study investigated whether Der f 1 can cleave the latency-associated peptide (LAP) of transforming
growth factor (TGF)-b via its proteolytic activity and activate latent TGF-b. We found that Der f 1 can
cleave LAP and induce the activation of latent TGF-b, leading to functional Smad signaling. Impor-
tantly, these actions of Der f 1 were inhibited by cysteine protease inhibitor E64 or inactivation of
the protease activity by heat. Thus, latent TGF-b may be a direct target of Der f 1 protease activity.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Der f 1 and Der p 1, derived from the house dust mites Dermato-
phagoides farinae and Dermatophagoides pteronyssinus, are major
allergens associated with asthma, atomic dermatitis, and allergic
rhinitis [1]. Both Der f 1 and Der p 1 belong to the papain-like cys-
teine protease family and their proteolytic activity has been sug-
gested to be linked to the potent allergenicity of house dust mites
[2] For instances, Der p 1 can cleave the tight-junction adhesion
protein occludin, thereby disrupting epithelial barrier function [3].
Transforming growth factor-b (TGF-b) is a ﬁbrogenic cytokine
that is involved in the pathophysiology of asthma [4]. TGF-b is se-
creted in a latent complex in which TGF-b homodimers are non-
covalently associated with homodimers of the pro-peptide called
the latency-associated peptide (LAP) [5,6]. The release of TGF-b
from its LAP is required for binding of TGF-b to the cellular recep-
tors and subsequent activation (phosphorylation) of intracellular
signaling mediators of Smad2 and Smad3 [7]. Extensive work onchemical Societies. Published by E
BE, Smad binding element;
en type I a2 chain; GAPDH,
mmunology, Faculty of Med-
, Yamanashi 409-3898, Japan.
o).the activation of latent TGF-b led to two classes of putative TGF-
b activators which liberate TGF-b from the constraints of LAP
through a conformational change or LAP proteolysis [5,6]. For in-
stances, extremely low or high pH activates latent TGF-b by alter-
ing the structure of LAP, whereas certain proteases activate latent
TGF-b through proteolytic digestion of LAP.
Given that both Der f 1 and TGF-b are involved in the patho-
physiology of asthma, we hypothesized that there might be a func-
tional link between Der f 1 and TGF-b. This study thus investigated
whether Der f 1 can cleave LAP via the protease activity and acti-
vate latent TGF-b in vitro. We then determined whether the intra-
tracheal challenge of Der f 1 induces the activation of latent TGF-b
in the mouse lung, resulting in increases in Smad promoter activity
and the expression of TGF-b target genes.2. Materials and methods
2.1. Reagents
Natural Der f 1 (Asahi Breweries, Tokyo, Japan), recombinant
human TGF-b1 LAP, TGF-b1, and latent TGF-b1 (TGF-b1 associated
with its LAP) (R&D Inc., Minneapolis, MN), HTS466284, a selective
small molecule inhibitor of TGF-b type I receptor kinase [8] (Cal-
biochem, San Diego, CA), and E64 (Peptide Institute, Osaka, Japan)
were purchased.lsevier B.V. All rights reserved.
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Reaction mixtures containing recombinant LAP, TGF-b1, latent
TGF-b1, and/or Der f 1 (1 lg for each) with or without 1000-fold
molar excess of E64 were incubated for the indicated times at
37 C in 100 ll PBS. For some experiments, Der f 1 (1 lg) was incu-
bated at 98 C for 30 min to inactivate the enzymatic activity and
then was added to the reaction mixtures.
2.3. Western blotting
For the detection of LAP protein, recombinant LAP, Der f 1, or
reaction mixture containing LAP and Der f 1 with or without E64
were boiled for 3 min in SDS sample buffer containing 5% 2-
mercaptoethanol (2-ME) and subjected to SDS–PAGE. Proteins
(50 ng/well) were then electrotransferred to nitrocellulose mem-
brane and subjected to immunoblotting with anti-human TGF-b1
LAP antibody (R&D Inc.) which can detect both homodimeric
(75 kDa) and monomeric forms (20–29 kDa) of LAP protein. For
the detection of TGF-b protein, the samples were dissolved in 2-
ME-free SDS sample buffer without boiling and subjected to immu-
noblotting with anti-human TGF-b1/2/3 antibody (1D11) (R&D
Inc.) because the antibody can detect only TGF-b homodimers
(25 kDa). For the detection of phosphorylated Smad2 in BEAS2B
cells, the whole cell extracts (10 lg) were subjected to immuno-
blotting with anti-phosphorylated Smad2 antibody, anti-Smad2/3
antibody, or b-actin antibody (all from Cell Signaling Technology
Inc., Danvers, MA).
2.4. Transcriptional reporter assay
A transcriptional reporter assay using (CAGA)12-luciferase re-
porter plasmid (CAGA12-luc), which is exclusively activated by
Smad3 and Smad4 [9], in human bronchial epithelial cell line
BEAS2B cells was performed as previously described [9]. Brieﬂy,
24 h after transfection of the reporter plasmid, the cells were
stimulated with the reaction mixtures containing latent TGF-b1
and/or Der f 1 (1 ng/ml for each) with or without E64, or 1 ng/
ml TGF-b1 in the presence or absence of 10 lM HTS466284.
Ninety-six hours after the stimulation, the luciferase activities
were measured.
2.5. Detection of endogenous Smad7 mRNA in BEAS2B cells
BEAS2B cells (1  106 well1) were stimulated with the reaction
mixtures containing latent TGF-b1 and/or Der f 1 (1 ng/ml for each)
with or without E64, or 1 ng/ml TGF-b1. Three hours after the stim-
ulation, total RNA was extracted and a real-time RT-PCR for human
Smad7 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was performed.
2.6. In vivo Der f 1 exposure
BALB/c mice (Japan SLC, Tokyo, Japan) were challenged intrana-
sal with 20 ll of Der f 1 (100 lg/ml) incubated with 50 lM E64 or
PBS for 30 min at 37 C or incubated at 98 C for 30 min to inacti-
vate the enzymatic activity prior to the challenge. The experimen-
tal protocols were approved by the Institutional Animal Care and
Use Committee of the University of Yamanashi.
2.7. Histology
Six hours after the Der f 1 challenge with or without E64, mouse
lungs were removed, ﬁxed, and the tissue sections were stained
with hematoxylin and eosin (H&E).2.8. Measurement of TGF-b activity in bronchoalveolar lavage (BAL)
ﬂuid
BAL ﬂuid samples were collected 6 h after Der f 1 challenge.
TGF-b activity in the BAL ﬂuid samples was then determined using
MFB-F11 cells stably transfected with the reporter plasmid con-
taining 12 CAGA boxes (Smad binding element, SBE), fused to a se-
creted alkaline phosphatase (SEAP) reporter gene [10]. Brieﬂy,
MFB-F11 cells (4  104 cells/well) in 96-well ﬂat-bottom tissue
culture plates (BD Falcon, San Jose, CA) were incubated in 50 ll
serum-free DMEM for 2 h and then BAL ﬂuid samples or TGF-b (5
and 10 pg/ml) were added in 50 ll volume in the presence or ab-
sence of 10 lM HTS466284. Following 24 h incubation, SEAP activ-
ity in the culture supernatants was measured using Gene Light 55
(Microtec nition, Chiba, Japan).
2.9. Quantitative real-time RT-PCR using mouse lung samples
Six hours after Der f 1 challenge with or without E64, the right
lung was homogenized and total RNA was extracted. A real-time
RT-PCR analysis for mouse TGF-b2, Smad7, collagen type I a2 chain
(COL1A2), and GAPDH was then performed.
2.10. Bioluminescence imaging
Bioluminescence was detected with the In Vivo Imaging System
(IVIS; Xenogen, Alameda, CA) using transgenic mouse lines T9-7F
or T9-55F harboring a SBE-luc transgene [11]. This transgene con-
sists of 12 SBE repeats fused to a herpes simplex virus/thymidine
kinase minimal promoter upstream of ﬁreﬂy luciferase followed
by a simian virus 40 late polyadenylation signal. Six hours after
an intratracheal challenge with Der f 1, the mice were anesthetized
and injected i.p. with 150 mg/kg D-luciferin (Sigma–Aldrich). Five
minutes later, the mice were anesthetized with an overdose of Hal-
othane and killed by cervical dislocation. The lungs were then rap-
idly dissected, placed in 24-well culture discs and imaged exactly
10 min after the initial luciferin administration. Photons emitted
from the lungs were acquired as photons per s/cm2 per steridian
(sr) by using LIVINGIMAGE software (Xenogen) and integrated
over 5 min. For photon quantiﬁcation, a region of interest was
manually selected; the signal intensity was converted into photons
per s/cm2 per sr.
2.11. Data analysis
The data are summarized as the mean ± S.D. Statistical analysis
was performed using a non-parametric Mann–Whitney U-test to
compare data in different groups. A value of P < 0.05 was consid-
ered to be signiﬁcant.3. Results and discussion
3.1. Der f 1 can cleave LAP and induce activation of latent TGF-b
in vitro
To investigate whether Der f 1 can cleave LAP, recombinant
TGF-b1 LAP (LAP) was incubated with natural Der f 1 and then
analyzed by Western blotting with anti-LAP antibody (Fig. 1A).
Following incubation, LAP (29 kDa) was cleaved at 15 min after
incubation and the cleaved LAP protein fragment (approximately
20 kDa) appeared. As a control, complete cleavage of LAP by incu-
bation with trypsin was observed. Importantly, the ability of Der f
1 to cleave LAP was lost by the co-incubation of E64, a cysteine
protease inhibitor, with Der f 1 or by the prior inactivation of the
protease activity of Der f 1 by heat. In contrast, the incubation of
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Fig. 1. Der f 1 can cleave LAP and induce activation of latent TGF-b, depending on the protease activity. (A)–(E) Recombinant LAP or TGF-b1 was incubated in the presence or
absence of Der f 1 with or without E64 or was incubated with Der f 1 inactivated by heat. The reaction mixtures were then immunoblotted with anti-LAP antibody (A) or anti-
TGF-b1 antibody (B) or were assayed by a reporter analysis using CAGA12-luc plasmid in BEAS2B cells (C), or were added to BEAS2B cell culture for the indicated times and the
cell lysates were subjected to a Western blot analysis with anti-phosphorylated Smad2 (pSmad2) or Smad2 antibody (D), or were added to BEAS2B cell culture for the
indicated times and real-time PCR was performed for the detection of Smad7 mRNA (E). *P < 0.05.
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protein (25 kDa) (Fig. 1B). These results indicated that Der f 1 can
cleave LAP, depending on its cysteine protease activity.
To investigate whether Der f 1 can activate latent TGF-b, the
TGF-b-inducible (CAGA)12-luciferase reporter construct was trans-
fected into BEAS2B cells and then the transfected cells were stim-
ulated with the reaction mixtures containing latent TGF-b1
(LAP + TGF-b1) and/or Der f 1 (Fig. 1C). Stimulation of the transfec-
ted cells with latent TGF-b1 increased luciferase activity to some
extent possibly due to non-speciﬁc activation of latent TGF-b1 dur-
ing preparation processes (e.g. by stirring). The reaction mixtures
containing latent TGF-b1 and Der f 1 signiﬁcantly increased the
luciferase activities in comparison to the reaction mixtures con-
taining latent TGF-b1 alone. The ability of Der f 1 to increase the
luciferase activity was lost by the co-incubation of E64 with Der f
1 or by the prior inactivation of the protease activity of Der f 1
by heat. Importantly, the increase in the luciferase activity induced
by the reaction mixtures containing latent TGF-b1 and Der f 1 was
completely abrogated by the addition of HTS466284, a TGF-b type I
receptor kinase inhibitor, thus conﬁrming that the increase of lucif-
erase activity totally depends on TGF-b activity.
In addition, the ability of Der f 1 to activate latent TGF-b was
examined by the detection of phosphorylation of Smad2 in BEAS2B
cells (Fig. 1D). The reaction mixtures containing latent TGF-b1 and
Der f 1 induced phosphorylation of Smad2 in BEAS2B cells, begin-
ning at 30 min after the stimulation. The Der f 1-induced phos-
phorylation of Smad2 was lost by the co-incubation of E64 with
Der f 1 or by the prior inactivation of the protease activity of Der
f 1 by heat.
Furthermore, the ability of Der f 1 to activate latent TGF-b was
examined by the detection of endogenous Smad7, a major TGF-b
target gene [12], mRNA induction in BEAS2B cells (Fig. 1E). Stimu-lation of the transfected cells with latent TGF-b1 (LAP + TGF-b1) in-
creased Smad7 mRNA expression to some extent. The reaction
mixtures containing latent TGF-b1 and Der f 1 signiﬁcantly in-
creased Smad7 mRNA expression in comparison to the reaction
mixtures containing latent TGF-b1 alone. The ability of Der f 1 to
increase Smad7 mRNA expression was lost by the co-incubation
of E64 with Der f 1 or by the prior inactivation of the protease
activity of Der f 1 by heat. These results indicated that Der f 1
can induce the activation of latent TGF-b via its cysteine protease
activity in vitro. Given the earlier ﬁndings (Fig. 1A), it is very likely
that the Der f 1-induced cleavage of LAP is responsible for the acti-
vation of latent TGF-b.
3.2. Intratracheal exposure of Der f 1 to mice induces TGF-b activity in
BAL ﬂuids and expression of TGF-b target genes in the lungs
The normal adult mouse lung expresses all isoforms of mamma-
lian TGF-b protein (-b1, -b2, and -b3), most likely as the latent
forms [13]. To determine whether Der f 1 induces the activation
of latent TGF-b expressed in the mouse lung, the mice were intrat-
racheally exposed to Der f 1 and then the BAL ﬂuid and the lung tis-
sue samples were immediately (6 h following the challenge)
obtained in order to measure the TGF-b activity and expression
levels of TGF-b target genes (TGF-b itself [14], Smad7 [12], and
COL1A2 [15]), respectively.
To detect the TGF-b activity in BAL ﬂuid samples, MFB-F11 re-
porter cells were used (Fig. 2A). The BAL ﬂuid samples obtained
from PBS-challenged mice did not show any increase in SEAP activ-
ity, whereas the BAL samples obtained from Der f 1-challenged
mice showed a signiﬁcant increase in SEAP activity. Importantly,
this SEAP activity was detected without any activation of the sam-
ples, suggesting that TGF-b was already activated in the BAL ﬂuid
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with a Der f 1 and E64 mixture showed decreased SEAP activity
in comparison to those obtained from Der f 1-challenged mice. In
addition, BAL ﬂuid samples obtained from the mice challenged
with Der f 1 of which the protease activity was inactivated by heat
showed decreased SEAP activity in comparison to those obtained
from Der f 1-challenged mice. We conﬁrmed that these SEAP activ-
ities relied on TGF-b activity in the BAL ﬂuid samples because the
addition of HTS466284 in the MFB-F11 cell culture abolished all
the SEAP activity.
Consistent with these ﬁndings, the increases in the transcrip-
tion of major TGF-b target genes TGF-b2, Smad7, and COL1A2 wereB
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rapidly dissected mouse lungs were imaged with a bioluminescence imaging system
performed (E). *P < 0.05.observed in the lungs obtained from mice challenged with Der f 1,
but not with PBS (Fig. 2B). The Der f 1-induced increases in TGF-b2,
Smad7, and COL1A2 mRNAs were abrogated by the treatment of
Der f 1 with E64.
We found that the lung tissue sections obtained from Der f
1-challengedmiceat this point (6 hafter the challenge)didnot show
any overt pathological changes (e.g. inﬂammation) (Fig. 2C). Thus,
the increases in TGF-b activity and target gene expressions in the
mouse lung following Der f 1 challenge are likely to reﬂect the acti-
vation of latent TGF-b, which is not associated with inﬂammation.
To further conﬁrm that Der f 1 leads to the activation of TGF-b
signaling in vivo, SBE-luc mice were used. These mice harbor a0.00E+00
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2092 Y. Nakamura et al. / FEBS Letters 583 (2009) 2088–2092TGF-b/Smad-responsive luciferase reporter gene and have been
shown to reliably indicate activation of TGF-b/Smad signaling
[11]. Consistent with the earlier results, the intratracheal challenge
of Der f 1 to SBE-luc mice resulted in an increase in the emission of
bioluminescence from the lungs (Fig. 2D and E).
Natural Der f 1 had the ability to activate latent TGF-b in vitro
without any manipulations known to reduce oxidized catalytic
cysteine residue of cysteine proteases such as adding cysteine or
DTT (Fig. 1). This is consistent with the recent report by Ogawa
et al. who showed that natural non-activated Der f 1 can induce
GM-CSF and IL-8 production in human keratinocytes [16]. They
speculated that the oxidized catalytic cysteine residue of Der f 1
could be reduced by interaction with the cells or components in
the culture supernatant including cell-derived factors. Similar
speculation could be applied to the current experimental system.
Where and how the cysteine protease activity of Der f 1 (or Der
p 1) can be activated in vivo also remain critical issues in this ﬁeld.
Herbert et al. speculated that Der p 1 could be activated by reduc-
tion with glutathione present in airway tissue on the basis of their
in vitro results [17]. These issues remain to be clariﬁed in future
studies.
TGF-b plays an important role for the pathophysiology of asth-
ma, particularly in ﬁbrotic changes of asthmatic airways termed
‘‘airway remodeling” [4]. Recent evidence suggests that airway
remodeling may occur very early in asthma pathogenesis, indepen-
dent of inﬂammation [18]. For instances, there were increases in
the number of phosphorylated Smad2-positive epithelial cells in
mucosal biopsy specimens obtained at 24 h after allergen chal-
lenge in patients with asthma along with ﬁbrotic changes of the
airways [19]. The identiﬁcation of latent TGF-b as a possible direct
target of Der f 1 protease activity might provide an experimental
support for the notion that airway remodeling may occur early in
asthma pathogenesis and shed new light on the pathogenesis of
airway remodeling in asthma or remodeling observed in other
house dust mite-related allergic diseases.
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